BOLINGBROOK, Ill., May 10, 2023 /PRNewswire/ -- ATI Physical Therapy ("ATI" or the "Company") (NYSE: ATIP), a nationally recognized outpatient physical therapy provider in the United States, today announced the opening of two new locations in the growing Dallas-Fort Worth metroplex, bringing its total number of clinics in the market to 55. The expansion creates even more opportunity for Dallas-area residents to access high quality care, personalized service and treatment by dedicated therapists chosen from some of the best clinicians in the industry.
According the Washington Post, Americans continue to prioritize personal health and wellness coming out of the pandemic. ATI Physical Therapy specializes in evidence-based, hands-on care for a variety of individuals with a core focus on improving and sustaining musculoskeletal health through better movement. Key services include Sports Therapy, Women's Health PT, Hand Therapy, Worker's Comp Rehab, all anchored in a personalized rehabilitation treatment approach.
"Physical therapy complements any type of wellness routine, from rehab and injury recovery, to returning to athletic competition, to improving overall body mobility and reducing pain so you can get back to life," said Dr. Chuck Thigpen, PhD, PT, ATC, Senior Vice President of Clinical Excellence, ATI Physical Therapy. "We're excited to expand our presence in Dallas-Fort Worth, increasing access to convenient care and bringing our industry-leading expertise to local residents."
"Opening these two new clinics is in keeping with our strategy of driving growth within our existing clinic footprint," said Scott Gregerson, Chief Growth Officer, ATI Physical Therapy. "The Dallas-Fort Worth Metroplex continues to be a focus for ATI as is the state of Texas in general. We will continue to focus on deepening our community connections and partnerships in markets like this as part of our work to drive access to high-quality, affordable care."
ATI Physical Therapy introduces the following locations:
Events at the Arlington Eastchase location will include a Blood Flow Restriction (BFR) therapy demonstration by certified BFR specialist Richie Daniel, PT, DPT, OCS, CMPT, and complimentary injury screens for the general public between the hours of 10:30 a.m. to 12:30 p.m. A ceremonial ribbon-cutting will take place at 11:15 a.m.
A ceremonial ribbon-cutting will take place at the Dallas North – Preston Beltline location at 5:15 p.m.
Both events will include presentations of $10,000 grants from the ATI Foundation to recipients chosen based on need and individual circumstances. A third $10,000 grant will be awarded to another recipient later that evening at a private ATI event at the Plano – Coit Road clinic.
ABOUT ATI PHYSICAL THERAPY
At ATI Physical Therapy, we are passionate about potential. Every day, we restore it in our patients and activate it in our team members in our more than 900 locations in 24 states. With outcomes from more than 3 million unique patient cases, ATI is making strides in the industry by setting quality standards designed to deliver predictable outcomes for our patients with musculoskeletal (MSK) issues. ATI's offerings span across a broad spectrum for MSK-related issues. From preventative services in the workplace and athletic training support to outpatient clinical services and online physical therapy via our online platform, CONNECT™, a complete list of our service offerings can be found at ATIpt.com. ATI is based in Bolingbrook, Illinois.
Contact:
Michelle Ravelo
Garbo Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.
714-403-9534
Rob Manker
Director of Customer Marketing & Public Relations
ATI Physical Therapy
This email address is being protected from spambots. You need JavaScript enabled to view it.
630-296-2222 x7432
Last Trade: | US$5.00 |
Daily Change: | 0.37 7.99 |
Daily Volume: | 7,764 |
Market Cap: | US$22.000M |
May 01, 2024 February 26, 2024 February 20, 2024 November 06, 2023 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB